» Articles » PMID: 18383361

T Cell Polarization Identifies Distinct Clinical Phenotypes in Scleroderma Lung Disease

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2008 Apr 3
PMID 18383361
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Lung involvement is the leading cause of morbidity and mortality in systemic sclerosis (SSc; scleroderma), and interstitial lung disease (ILD) is the most common pulmonary manifestation. An abnormal profibrotic Th2/Tc2-polarized T cell response is postulated to mediate tissue damage and fibrosis. The aim of this study was to investigate whether a polarized T cell phenotype in SSc is associated with lung disease or other clinical manifestations of SSc.

Methods: Circulating T cells were characterized by flow cytometry in 62 patients with SSc and 36 healthy control subjects, using antibodies against CD3, CD4, CD8, chemokine receptor CCR5 (Th1/Tc1-specific), and prostaglandin D2 receptor CRTH2 (Th2/Tc2-specific). The ratio between CCR5 and CRTH2 T cell frequencies was used to quantify type 1 (high-ratio) or type 2 (low-ratio) immune polarization.

Results: Patients with SSc exhibited lower CCR5/CRTH2 T cell ratios than those exhibited by control subjects (P<0.0001), indicating a Th2/Tc2-polarized phenotype. Markedly reduced CCR5/CRTH2 T cell ratios were observed in SSc patients with ILD compared with SSc patients without ILD (P<0.0001), particularly in patients with active ILD (P<0.0001) compared with those with stable lung function. Lower CCR5/CRTH2 ratios were strongly associated with a lower value for the percent predicted forced vital capacity (P<0.0001). In patients with an estimated right ventricular systolic pressure>35 mm Hg, suggestive of pulmonary vascular disease, a lower value for the percent predicted diffusing capacity (DLCO) was associated with higher CCR5/CRTH2 T cell ratios (Th1/Tc1) (P=0.009), while in those with right ventricular systolic pressure<35 mm Hg, a lower value for the percent predicted DLCO correlated with lower ratios (Th2/Tc2) (P<0.0001), as observed for ILD.

Conclusion: T cell polarization in SSc is strongly associated with specific manifestations of lung disease. Measurement of T cell polarization may represent a valuable tool to monitor disease activity and predict clinical outcomes in SSc patients with lung disease.

Citing Articles

Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis.

Renaud L, Wilson C, Lafyatis R, Schnapp L, Feghali-Bostwick C iScience. 2024; 27(6):110010.

PMID: 38868196 PMC: 11167435. DOI: 10.1016/j.isci.2024.110010.


Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.

Petelytska L, Bonomi F, Cannistra C, Fiorentini E, Peretti S, Torracchi S RMD Open. 2023; 9(4).

PMID: 37940340 PMC: 10632935. DOI: 10.1136/rmdopen-2023-003426.


Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Gumkowska-Sroka O, Kotyla K, Mojs E, Palka K, Kotyla P Pharmaceuticals (Basel). 2023; 16(8).

PMID: 37630981 PMC: 10458905. DOI: 10.3390/ph16081066.


Type 2 cytokines and scleroderma interstitial lung disease.

Pellicano C, Vantaggio L, Colalillo A, Pocino K, Basile V, Marino M Clin Exp Med. 2023; 23(7):3517-3525.

PMID: 37392249 PMC: 10618297. DOI: 10.1007/s10238-023-01125-x.


Increased CD8+ tissue resident memory T cells, regulatory T cells and activated natural killer cells in systemic sclerosis lungs.

Padilla C, Valenzi E, Tabib T, Nazari B, Sembrat J, Rojas M Rheumatology (Oxford). 2023; 63(3):837-845.

PMID: 37310903 PMC: 10907815. DOI: 10.1093/rheumatology/kead273.


References
1.
Messi M, Giacchetto I, Nagata K, Lanzavecchia A, Natoli G, Sallusto F . Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol. 2002; 4(1):78-86. DOI: 10.1038/ni872. View

2.
Bouros D, Wells A, Nicholson A, Colby T, Polychronopoulos V, Pantelidis P . Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002; 165(12):1581-6. DOI: 10.1164/rccm.2106012. View

3.
LeRoy E, Medsger Jr T . Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001; 28(7):1573-6. View

4.
De Fanis U, Mori F, Kurnat R, Lee W, Bova M, Adkinson N . GATA3 up-regulation associated with surface expression of CD294/CRTH2: a unique feature of human Th cells. Blood. 2007; 109(10):4343-50. PMC: 1885489. DOI: 10.1182/blood-2006-05-025940. View

5.
KNUDSON R, Kaltenborn W, Knudson D, Burrows B . The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit. Am Rev Respir Dis. 1987; 135(4):805-11. DOI: 10.1164/arrd.1987.135.4.805. View